Action SMIH SUMT HEAL
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues SUMT HEAL

Actions

SMIH

KYG8566R1020

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
SUMMIT HEALTHCARE ACQUISITION CORP. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers (form 8-K)
Summit Healthcare Acquisition Corp. Announces Board Changes
Summit Healthcare Acquisition Corp. Announces Resignation of Bo Tan as Chief Executive Officer
Summit Healthcare Acquisition Corp.(NasdaqCM:SMIH) dropped from NASDAQ Composite Index
Yisheng Biopharma Co., Ltd. completed the acquisition of Summit Healthcare Acquisition Corp. from Summit Healthcare Acquisition Sponsor LLC and others in a reverse merger transaction.
Summit Healthcare Acquisition, YS Biopharma Business Combination Gets Shareholder Approval
SUMMIT HEALTHCARE ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events (form 8-K)
YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION
SUMMIT HEALTHCARE ACQUISITION CORP. : Other Events (form 8-K)
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION
SUMMIT HEALTHCARE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
SUMMIT HEALTHCARE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
SUMMIT HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Summit Healthcare Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Bolsa de Madrid: Precaución, frágil
SUMMIT HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Regulation FD Disclosure (form 8-K)
Yisheng Biopharma Co., Ltd. agreed to acquire Summit Healthcare Acquisition Corp. from Summit Healthcare Acquisition Sponsor LLC and others in a reverse merger transaction.
SUMMIT HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Summit Healthcare Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
SUMMIT HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action SMIH
  4. Actualités SUMT HEAL
  5. Autres langues